Clinical trials: Allergic Rhinitis Due to Allergens

Allergic Rhinitis Due to Grass Pollen

Is Intralymphatic Allergen Immunotherapy Effective and Safe?

• Completed
• Age: 18 to 55 years
• Phase 2/3

15 patients with moderate to severe allergic rhinitis against grass were recruited and enrolled in the study. They received three open label intralympatic grass allergen injections with the dose 1000 SQ-U each and with one month…

Trial name

NCT04210193

Testing

ALK Alutard 5-grasses, ALK Diluent

Where

Sweden

Volunteers

15 people

Sponsor

Lars Olaf Cardell